𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy

✍ Scribed by Michelle Shayne; Jeffrey Crawford; David C. Dale; Eva Culakova; Gary H. Lyman; for the ANC Study Group

Publisher
Springer US
Year
2006
Tongue
English
Weight
295 KB
Volume
100
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The cost of adjuvant chemotherapy in pat
The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma
✍ Nina Oestreicher; Scott D. Ramsey; Jeannine S. McCune; Hannah M. Linden; David L πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 1 views

## Abstract ## BACKGROUND In the U.S., the majority of premenopausal patients with early‐stage breast carcinoma are treated with adjuvant chemotherapy. However, to the authors' knowledge, there have been few formal analyses of adjuvant chemotherapy cost performed to date, especially in premenopaus

Dose intensity of mitomycin C in adjuvan
Dose intensity of mitomycin C in adjuvant cancer chemotherapy for patients with gastric cancer
✍ Tetsuro Kubota; Koichiro Kumai; Masaki Kitajima; Osahiko Abe; Masato Fujisaki; Y πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 521 KB

Using a cohort of macroscopic curative resections of gastric cancer at stages 11, Ill, and IV, a randomized controlled trial was performed to clucidate the dose efficacy of intensive adjuvant cancer chemotherapy with mitomycin C. Between June 1983 and December 1986, 336 patients with gastric cancer